Sign In
Buy OPY
$106.64
-4.06 (-3.67%)
At Close: Jul 31, 2026
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by National Bank of Canada FI
05:06am, Monday, 20'th May 2024
National Bank of Canada FI lessened its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 63.7% during the fourth quarter, according to the company in its most recent 13F filing wit
Russell Investments Group Ltd. Acquires 59,267 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE)
05:04am, Monday, 20'th May 2024
Russell Investments Group Ltd. increased its holdings in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 34.0% during the fourth quarter, according to the company in its most re
Zurn Elkay Water Solutions Co. (NYSE:ZWS) Shares Sold by Amalgamated Bank
05:04am, Monday, 20'th May 2024
Amalgamated Bank lessened its holdings in shares of Zurn Elkay Water Solutions Co. (NYSE:ZWS – Free Report) by 9.3% during the 4th quarter, according to its most recent 13F filing with the SEC.
Oppenheimer Expands Technology Investment Banking Group with Addition of Yogesh Amle
11:51am, Monday, 13'th May 2024
Senior banker brings two decades of technology investment banking experience to firm's software team NEW YORK , May 13, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investme
Oppenheimer Expands Its Investment Banking Capabilities with the Hires of Dmitry Gladkov and Konstantin Derkatschew
06:00am, Wednesday, 08'th May 2024
Highly experienced, London-based bankers to lead firm's newly established Capital Markets Group focused on Emerging Markets. NEW YORK , May 8, 2024 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer)
Oppenheimer Holdings Inc. Reports First Quarter 2024 Earnings
09:20am, Friday, 26'th Apr 2024
NEW YORK , April 26, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $26.1 million or $2.50 basic earnings per share for the first quar
Oppenheimer & Co. Inc. Appoints William Bird Director of Equity Research
06:00am, Wednesday, 03'rd Apr 2024
Bird Has More Than 30 Years of Experience as a Top-Performing Analyst, Portfolio Manager and Management Strategy Consultant NEW YORK , April 3, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheime
Oppenheimer Further Expands Public Finance Banking Team with Appointment of Frank Sanchez Reed As Head of the Southwest Region
04:01pm, Tuesday, 12'th Mar 2024
Texas-Based Senior Banker, Who Has Nearly 30 Years of Public Finance Experience, Builds on Oppenheimer's Continued Momentum in the Space Reed's Recruitment Follows the Hires of Northeast Region Head K
Oppenheimer Holdings Inc. Announces Share Repurchase Program
08:00am, Monday, 04'th Mar 2024
NEW YORK , March 4, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) today announced that its Board of Directors approved a share repurchase program that authorizes the Company to purchase up
Google is putting too many guardrails on its AI, says Oppenheimer's Jason Helfstein
06:31pm, Monday, 26'th Feb 2024
Jason Helfstein, Oppenheimer internet equity research managing director, joins 'Fast Money' to talk Google's AI struggles and where it goes from here.
The market is too optimistic about a rebound in home improvement, says Oppenheimer's Brian Nagel
04:14pm, Thursday, 15'th Feb 2024
Brian Nagel, senior equity analyst at Oppenheimer, joins 'Closing Bell' to discuss the weak retail sales numbers and his read on the consumer.
Oppenheimer & Co. Inc. Announces 34th Annual Healthcare Life Sciences Conference
06:00am, Tuesday, 13'th Feb 2024
Virtual Event Gathers Over 140 Leading Companies for Presentations and Fireside Chats, Hosted by Oppenheimer's Healthcare Equity Research Analysts Conference Combines In-Depth Discussions Between Exec
Oppenheimer Further Expands Public Finance Banking Team with Appointments of Kristin Stephens and David Moffett
06:00am, Thursday, 08'th Feb 2024
Stephens will Head Up the Northeast Region while Moffett will Lead the Southeast Region; Each Has Over 20 Years of Public Finance and Municipal Capital Markets Experience, and will Serve as a Managing
Goldman Sachs, Jefferies stand out among undervalued big banks, Oppenheimer says
08:05am, Wednesday, 31'st Jan 2024
Oppenheimer analyst Chris Kotowski has reiterated overweight ratings on Goldman Sachs Group Inc. and Jefferies Financial Group Inc. as standouts among a class of relatively cheap big-bank stocks.
Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2023 Earnings
08:00am, Friday, 26'th Jan 2024
NEW YORK , Jan. 26, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $11.1 million or $1.07 basic earnings per share for the fourth quar
